AstraZeneca is giving Pascal Soriot a pay raise as the longtime CEO weathered a year of “significant geopolitical uncertainty ...

Increase of 6.4% comes as drugmaker reports strong profit growth, despite cancelling UK investment projects ...

Feb 24 (Reuters) - AstraZeneca Chief Executive Pascal Soriot's 2025 pay rose 6.4% to 17.7 million pounds ($23.87 million) ...

Swedish-British pharmaceutical and biotechnology giant AstraZeneca revealed that CEO Pascal Soriot received £17.7 million ($23.9 million) in pay and bonuses in 2025, with his total package potentially ...

AstraZeneca’s CEO, a French-born Australian running an Anglo-Swedish company, is betting $50 billion on a strategy of making the US its largest market — while also pouring $15 billion into China. Each ...

AstraZeneca (AZN) is shifting its focus to the US, calling itself an "American company" on Tuesday as it ramps up manufacturing and proposes price cuts for the US market. CEO Pascal Soriot told ...

Add Yahoo as a preferred source to see more of our stories on Google. U.S. President Donald Trump speaks during an announcement about lowering U.S. drug prices next to Secretary of Commerce Howard ...

Astrazeneca boss Pascal Soriot was handed his largest ever pay package last year - taking his total earnings at the pharma ...

The “most favored nation” (MFN) drug pricing deal AstraZeneca recently signed with the Trump administration won’t affect the British pharma’s revenue target, CEO Pascal Soriot said. “We can absorb the ...

LONDON (Reuters) - A number of investor advisory groups have called on AstraZeneca shareholders to oppose plans to increase Chief Executive Pascal Soriot's pay package when the COVID-19 vaccine maker ...

AstraZeneca boss Pascal Soriot nets £17.7m in pay and bonuses for 2025 - The drug maker’s annual report showed his total pay lifted 6.4% last year after he was awarded nearly £16 million in bonuses ...